The prevalence of extended-spectrum beta lactamase-producing Escherichia coli and Klebsiella pneumoniae in clinical isolates and risk factors

Saudi Medical Journal

Volumn 27, Issue 5, 2006, Pages 608-612

  Ozgunes, Ilhan ^a   Erben, Nurettin ^a   Kiremitci, Abdurahman ^a   Kartal, Elif D ^a   Durmaz, Gul ^a   Colak, Hasan ^a   Usluer, Gaye ^a   Colak, Ertugrul ^a  

^a ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; AZTREONAM; CEFAZOLIN; CEFOPERAZONE; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; OFLOXACIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOBRAMYCIN;

ADULT; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIUM ISOLATE; BALLOON CATHETER; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CONTROLLED STUDY; DEVICE INFECTION; DEVICE REMOVAL; ESCHERICHIA COLI; FEMALE; HEALTH CARE POLICY; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; INFECTION RISK; INTENSIVE CARE UNIT; INTRAVENOUS CATHETER; INTUBATION; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NONHUMAN; OUTPATIENT; PREVALENCE; STRAIN DIFFERENCE; SURGICAL INFECTION; TURKEY (REPUBLIC); VENTILATOR ASSOCIATED INFECTION; WARD;

ADULT; ANTI-INFECTIVE AGENTS; BETA-LACTAMASES; CATHETERS, INDWELLING; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HOSPITALS, TEACHING; HUMANS; INTUBATION; KLEBSIELLA PNEUMONIAE; MALE; MICROBIAL SENSITIVITY TESTS; PNEUMONIA, BACTERIAL; PREVALENCE; RISK FACTORS; SURGERY; TURKEY; URINARY CATHETERIZATION; VENTILATORS, MECHANICAL;

EID: 33646545027     PISSN: 03795284     EISSN: 03795284     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Knothe H, Shah P, Krcmery V, Antal M, Mitsuhashi S. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 1983; 11: 315-317.
2. Medeiros AA. Evolution and dissemination of β-lactamases accelerated by generations of β-lactam antibiotics. Clin Infect Dis 1997; 24 (Suppl 1): 19-45.
3. Lautenbach E, Strom BL, Bilker WB, Patel JB, Edelstein PH, Fishman NO. Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Clin Infect Dis 2001; 33: 1288-1294.
4. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing: Eleventh informational supplement 2001; 21: 40-44. Available from URL: http://www.nccls.org
5. Katsanis GP, Spargo J, Ferraro MJ, Sutton L, Jacoby GA. Detection of Klebsiella pneumoniae and Escherichia coli strains producing extended-spectrum β-lactamases. J Clin Microbiol 1994; 32: 691-696.
6. Jacoby GA, Han P. Detection of extended-spectrum β-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli. J Clin Microbiol 1996; 34: 908-911.
7. Bradford PA. Extended-spectrum beta-lactamases in the 21st century: Characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001; 14: 933-951.
8. Livermore DM, Yuan M. Antibiotic resistance and production of extended-spectrum beta-lactamases amongst Klebsiella spp. from intensive care units in Europe. J Antimicrob Chemother 1996; 38: 409-424.
9. Kim BN, Woo JH, Kim NM, Ryu J, Kim YS. Clinical implications of extended-spectrum beta-lactamase producing Klebsiella pneumoniae bacteraemia. J Hosp Infect 2002; 52: 99-106.
10. Pena C, Pujol M, Ardanuy C, Ricart A, Pallares R, Linores J, et al. An outbreak of hospital-acquired Klebsiella pneumoniae bacteraemia, including strains producing extended-spectrum beta-lactamase. J Hosp Infect 2001; 47: 53-59.
11. Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 2001; 32:1162-1171.
12. Lin MF, Huang ML, Lai SH. Risk factors in the acquisition of extended-spectrum beta-lactamase Klebsiella pneumoniae: a case-control study in a district teaching hospital in Taiwan. J Hosp Infect 2003; 53: 39-45.
13. Pena C, Pujol M, Ardanuy C Ricart A, Pallares R, Linores J, et al. Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum β-lactamases. Antimicrob Agents Chemother 1998; 42: 53-58.
14. Kim YK, Pai H, Lee HJ, Park SE, Choi EH, Kim J, et al. Bloodstream infections by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome. Antimicrob Agents Chemother 2002; 46: 1481-1491.
15. Itokazu GS, Quin JP, Bell-Dixon C, Kahan FM, Weinstein RA. Antimicrobial resistance rates among aerobic gram negative bacilli recovered patients in intensive care unit: evaluation of a national post marketing surveillance program. Clin Infect Dis 1996; 23: 779-784.